Lifecore Biomedical, Inc.
LFCR
$6.17
-$0.01-0.16%
| 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | 11/26/2023 | |
|---|---|---|---|---|---|
| Net Income | 59.51% | -129.14% | -145.31% | 9.95% | 232.21% |
| Total Depreciation and Amortization | 2.56% | 13.76% | -21.54% | 26.44% | -18.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.09% | -31.30% | 161.02% | 5.61% | -447.38% |
| Change in Net Operating Assets | -216.46% | 64.04% | 195.19% | -705.32% | 118.81% |
| Cash from Operations | -850.23% | -107.44% | 663.23% | -219.10% | 115.46% |
| Capital Expenditure | 27.18% | -28.63% | 57.81% | -46.70% | 15.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 27.18% | -28.63% | 57.81% | -46.70% | 15.69% |
| Total Debt Issued | -200.00% | -98.69% | 4,726.43% | 237.21% | -196.98% |
| Total Debt Repaid | -4,803.86% | 99.84% | -63,234.48% | -3.57% | -761.54% |
| Issuance of Common Stock | 2,383,900.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 34.63% | -1,011.32% | -26.19% | -250.00% | 73.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -102.19% | -- | -- |
| Cash from Financing | 1,045.01% | 278.01% | -108.04% | 411.97% | -183.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 233.75% | -154.59% | 3,741.22% | 97.27% | 48.12% |
